By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Eiger Biopharma 



Palo Alto  California    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS



Segment
Start Up





Company News
Eiger Biopharma Announces Completion Of Dosing In Phase 2 LOWR HDV - 3 Study At NIH 7/20/2016 6:35:02 AM
Eiger Biopharma Announces First Patient Dosed In Phase 2 LIBERTY Study Of Ubenimex In Pulmonary Arterial Hypertension 7/18/2016 6:33:35 AM
Eiger Biopharma To Present At The Cantor Fitzgerald 2nd Annual Healthcare Conference On July 12th 7/6/2016 7:45:41 AM
Eiger Biopharma Announces Positive Clinical Results Of Single Ascending Dose Study Of Subcutaneous Exendin (9-39) In Patients With Post-Bariatric Hypoglycemia 6/14/2016 11:13:28 AM
Eiger Biopharma To Participate In Jefferies 2016 Healthcare Conference 6/6/2016 12:23:27 PM
Eiger Biopharma Provides Corporate Update And Reports First Quarter 2016 Financial Results 5/17/2016 6:57:34 AM
Eiger Biopharma Announces First Patient Dosed In Phase 2 Multiple Ascending Dose Study Of Subcutaneous Exendin (9-39) In Patients With Hypoglycemia Post-Gastric Bypass Surgery 5/10/2016 6:21:34 AM
Eiger Biopharma Strengthens Senior Management Team With Announcement Of Debra Odink, PhD As Senior Vice President Of Technical Operations 5/3/2016 6:38:00 AM
Eiger Biopharma Announces License Of Worldwide Rights To Pegylated Interferon Lambda-1a From Bristol-Myers Squibb (BMY) 4/21/2016 6:02:29 AM
Eiger Biopharma Strengthens Board Of Directors With Addition Of Industry Veteran Charles J. "Chuck" Bramlage 4/4/2016 8:35:47 AM
1234
//-->